Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market - Global Outlook and Forecast 2022-2028
DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.
This report contains market size and forecasts of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in global, including the following market information:
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine companies in 2021 (%)
The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune DTaP Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Pfizer Inc and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine revenues share in global market, 2021 (%)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in global, including the following market information:
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine companies in 2021 (%)
The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune DTaP Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Pfizer Inc and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, by Type, 2021 (%)
- Immune DTaP Vaccine
- Therapy DTaP Vaccine
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, by Application, 2021 (%)
- Adult
- Pediatric
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine revenues share in global market, 2021 (%)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi Pasteur
- GlaxoSmithKline
- Protein Sciences Corporation
- Novartis AG
- Seqirus
- Merck Sharp & Dohme Corp
- Astellas Pharma US
- Pfizer Inc
- Johnson & Johnson
- Lanzhou Institute of Biological Products Co., Ltd
- AstraZeneca
- Emergent BioSolutions Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE OVERALL MARKET SIZE
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2021 VS 2028
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.2 Top Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies
3.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies
3.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Markets, 2021 & 2028
4.1.2 Immune DTaP Vaccine
4.1.3 Therapy DTaP Vaccine
4.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
4.3.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
5.3.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
6.3.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.4.3 US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.4.4 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.4.5 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.5.3 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.4 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.5 U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.6 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.7 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.9 Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.6.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.5 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.7 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.7.3 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.7.4 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.8.3 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.4 Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.6 UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporate Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Pasteur Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporate Summary
7.3.2 Protein Sciences Corporation Business Overview
7.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Protein Sciences Corporation Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Seqirus
7.5.1 Seqirus Corporate Summary
7.5.2 Seqirus Business Overview
7.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Seqirus Key News
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporate Summary
7.6.2 Merck Sharp & Dohme Corp Business Overview
7.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Merck Sharp & Dohme Corp Key News
7.7 Astellas Pharma US
7.7.1 Astellas Pharma US Corporate Summary
7.7.2 Astellas Pharma US Business Overview
7.7.3 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.7.4 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma US Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Inc Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.11.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.11.4 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporate Summary
7.12.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.12.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.12.4 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Emergent BioSolutions Inc Key News
8 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity, 2017-2028
8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Upstream Market
10.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE OVERALL MARKET SIZE
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2021 VS 2028
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.2 Top Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies
3.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies
3.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Markets, 2021 & 2028
4.1.2 Immune DTaP Vaccine
4.1.3 Therapy DTaP Vaccine
4.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
4.3.1 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
5.3.1 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales & Forecasts
6.3.1 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.4.3 US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.4.4 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.4.5 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.5.3 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.4 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.5 U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.6 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.7 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.5.9 Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.6.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.5 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.6.7 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.7.3 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.7.4 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, 2017-2028
6.8.3 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.4 Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
6.8.6 UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporate Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Pasteur Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporate Summary
7.3.2 Protein Sciences Corporation Business Overview
7.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Protein Sciences Corporation Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Seqirus
7.5.1 Seqirus Corporate Summary
7.5.2 Seqirus Business Overview
7.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Seqirus Key News
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporate Summary
7.6.2 Merck Sharp & Dohme Corp Business Overview
7.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Merck Sharp & Dohme Corp Key News
7.7 Astellas Pharma US
7.7.1 Astellas Pharma US Corporate Summary
7.7.2 Astellas Pharma US Business Overview
7.7.3 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.7.4 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma US Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Inc Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.11.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.11.4 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporate Summary
7.12.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business Overview
7.12.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Product Offerings
7.12.4 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Emergent BioSolutions Inc Key News
8 GLOBAL DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity, 2017-2028
8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DIPHTHERIA, TETANUS, AND PERTUSSIS (DTAP) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Upstream Market
10.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in Global Market
Table 2. Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 16. By Application – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 21. By Region – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 46. Sanofi Pasteur Corporate Summary
Table 47. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 48. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 51. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Protein Sciences Corporation Corporate Summary
Table 53. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 54. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 57. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Seqirus Corporate Summary
Table 59. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 60. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Merck Sharp & Dohme Corp Corporate Summary
Table 62. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 63. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Astellas Pharma US Corporate Summary
Table 65. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 66. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Pfizer Inc Corporate Summary
Table 68. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 69. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Johnson & Johnson Corporate Summary
Table 71. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 72. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
Table 74. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 75. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 78. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Emergent BioSolutions Inc Corporate Summary
Table 80. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 81. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 83. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2017-2022 (K Doses)
Table 85. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2023-2028 (K Doses)
Table 86. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Opportunities & Trends in Global Market
Table 87. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Drivers in Global Market
Table 88. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Restraints in Global Market
Table 89. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials
Table 90. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials Suppliers in Global Market
Table 91. Typical Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream
Table 92. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream Clients in Global Market
Table 93. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in Global Market
Table 2. Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 16. By Application – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 21. By Region – Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, (K Doses), 2023-2028
Table 46. Sanofi Pasteur Corporate Summary
Table 47. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 48. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 51. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Protein Sciences Corporation Corporate Summary
Table 53. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 54. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 57. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Seqirus Corporate Summary
Table 59. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 60. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Merck Sharp & Dohme Corp Corporate Summary
Table 62. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 63. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Astellas Pharma US Corporate Summary
Table 65. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 66. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Pfizer Inc Corporate Summary
Table 68. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 69. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Johnson & Johnson Corporate Summary
Table 71. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 72. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
Table 74. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 75. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 78. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Emergent BioSolutions Inc Corporate Summary
Table 80. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offerings
Table 81. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 83. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2017-2022 (K Doses)
Table 85. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Region, 2023-2028 (K Doses)
Table 86. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Opportunities & Trends in Global Market
Table 87. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Drivers in Global Market
Table 88. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Restraints in Global Market
Table 89. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials
Table 90. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials Suppliers in Global Market
Table 91. Typical Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream
Table 92. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream Clients in Global Market
Table 93. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
Figure 2. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application
Figure 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2021
Figure 9. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 19. US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 33. China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Region, 2021 VS 2028
Figure 50. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
Figure 2. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application
Figure 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2021
Figure 9. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 19. US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 33. China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Region, 2021 VS 2028
Figure 50. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Value Chain
Figure 51. Marketing Channels
